{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:04:50Z","timestamp":1784325890096,"version":"3.55.0"},"reference-count":41,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncol Pract"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Palliative care (PC) is an important facet of treatment for patients with advanced esophageal cancer because of symptom burden, low overall 5-year survival rate, and significant impact on quality of life. This patient population experiences high hospitalization burden. The purpose of this study was to analyze the effect of PC on end-of-life (EoL) hospitalizations and evaluate racial differences in EoL care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The National Inpatient Sample (NIS) was queried between 2016 and 2020 for hospitalizations with esophageal cancer that ended with inpatient death. The primary EoL outcomes that were identified include inpatient PC consultation (PCC), do not resuscitate (DNR) code status, and utilization of certain medical interventions (mechanical ventilation, blood transfusion, vasopressor administration, and chemotherapy). Secondary outcomes include symptom burden, length of stay (LOS), and total hospital charges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Seventeen thousand seven hundred forty-five hospitalizations were included, of which 10,370 (58.4%) received PCCs and 7,375 (41.6%) did not. Age and sex were not significantly different between the patients who did and did not receive PCC. PCC cohort had a higher percentage of White patients (60.9%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      39.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). PCCs resulted in shorter LOS (7.5\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      8.9 days,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), lower mean total hospital charges accumulated ($97,879 in US dollars [USD]\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      $146,128 [USD],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), and higher rates of DNR code status (78.1%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      43.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Inpatient PCC was also associated with lower rates of medical interventions (blood transfusions, mechanical ventilation, and chemotherapy). PCC was less likely to be performed among Black patients compared with White patients (adjusted odds ratio [aOR], 0.53 [95% CI, 0.48 to 0.58]). Black patients were also less likely to be DNR compared with White patients (aOR, 0.81 [95% CI, 0.74 to 0.90]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>PCCs at EoL were associated with higher rates of DNR and lower rates of medical interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/op-24-01092","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:59:32Z","timestamp":1757102372000},"page":"1238-1245","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Palliative Care Consultation and End-of-Life Care Among Patients With Esophageal Cancer and Inpatient Mortality"],"prefix":"10.1200","volume":"22","author":[{"given":"Suriya","family":"Baskar","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-3629","authenticated-orcid":true,"given":"Udhayvir Singh","family":"Grewal","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute at Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14745"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.76"},{"key":"e_1_3_4_4_2","first-page":"322","article-title":"Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States)","volume":"7","author":"Farrow DC","year":"1996","unstructured":"Farrow DC, Vaughan TL: Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 7:322-327, 1996","journal-title":"Cancer Causes Control"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030765"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31462-9"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.419"},{"key":"e_1_3_4_8_2","first-page":"CD005048","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"2014","author":"Yang C","year":"2014","unstructured":"Yang C, Li J, Fu W, et al: Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2014:CD005048, 2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07320-z"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2022.2114379"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.03.017"},{"key":"e_1_3_4_12_2","first-page":"337","article-title":"The impact of a palliative medicine consultation service in medical oncology","volume":"10","author":"Homsi J","year":"2002","unstructured":"Homsi J, Walsh D, Nelson KA, et al: The impact of a palliative medicine consultation service in medical oncology. Support Care Cancer 10:337-342, 2002","journal-title":"Support Care Cancer"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.12.017"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28628"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29485"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.14639"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9664-5"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","unstructured":"QuickStats: Percentage of Deaths by Place of Death\u2014National Vital Statistics System United States 2000\u20132018. 69:611 2020. https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6919a4.htm","DOI":"10.15585\/mmwr.mm6919a4"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.109-4500"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3863"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doy022"},{"key":"e_1_3_4_22_2","unstructured":"(HCUP) H.C.a.U.P. producing national HCUP estimates\u2014Accessible version. 2018. www.hcup-us.ahrq.gov\/tech_assist\/nationalestimates\/508_course\/508course_2018.jsp"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0219"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.04.005"},{"key":"e_1_3_4_27_2","article-title":"Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers","volume":"41","author":"Wang XS","year":"2023","unstructured":"Wang XS, Hess LM, Shen SE, et al: Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers. J Clin Oncol 41, 2023 (suppl 4; abstr 311)","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(00)00238-6"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851115)56:10<2512::AID-CNCR2820561032>3.0.CO;2-9"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102561"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5046"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049909120986800"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01038-6"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.8116"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14708"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-017-0670-9"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2018.01.007"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2079-x"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2013.9468"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2013.0164"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2018.100331"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.25092"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP-24-01092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:59:41Z","timestamp":1784325581000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP-24-01092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1200\/OP-24-01092"],"URL":"https:\/\/doi.org\/10.1200\/op-24-01092","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2024-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}